From: Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population
Criteria | Odds ratio (95% CI) | β coefficient | P value |
---|---|---|---|
Imaging and clinical characteristics | |||
Non-rim APHE | 6.73 (2.69, 16.84) | 1.91 (0.99, 2.82) | < 0.001 |
Washout | 6.61 (2.44, 17.95) | 1.89 (0.89, 2.89) | 0.001 |
Enhancing capsule | 9.37 (2.83, 31.07) | 2.24 (1.04, 3.44) | < 0.001 |
TNSI | 3.92 (1.60, 9.56) | 1.36 (0.47, 2.26) | 0.003 |
AFP ≥ 20 ng/ml | 39.68 (12.38, 127.17) | 3.68 (2.52, 4.85) | < 0.001 |
Sex (male) | 4.55 (1.85, 11.12) | 1.52 (0.61, 2.42) | 0.001 |
Imaging characteristics | |||
Non-rim APHE | 7.22 (3.46, 15.07) | 1.98 (1.24, 2.71) | < 0.001 |
Washout | 7.17 (3.33, 15.43) | 1.97 (1.20, 2.74) | < 0.001 |
Enhancing capsule | 9.70 (3.62, 25.93) | 2.27 (1.29, 3.26) | < 0.001 |
TNSI | 5.45 (2.61, 11.36) | 1.70 (0.96, 2.43) | < 0.001 |